The genetic alterations for high grade serous ovarian carcinoma observed in our study were similar to those found in contemporary studies, with the most common genes involved being TP53, BRCA1 and BRCA2 [5,12,13,14,15]. This evidence concerns the gene TP53 and ovarian serous carcinoma.